| Complexity in common diseases: big biology for all. | |
| | |
MedLine Citation:
|
PMID: 20424010 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Commentary of Mills and Sykes in Science Translational Medicine presented their thesis on the advent of high-throughput technologies and the dangers they may represent for the future of biomedical research. In response, we argue that true progress on the diagnosis and treatment of common human diseases will require the advent of big biology and its deep integration with focused research as practiced in both academic and industrial institutions. |
| | |
Authors:
|
John R Lamb; Neil W Gibson |
Publication Detail:
|
Type: Comment; Journal Article |
Journal Detail:
|
Title: Science translational medicine Volume: 2 ISSN: 1946-6242 ISO Abbreviation: Sci Transl Med Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-04-28 Completed Date: 2010-07-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101505086 Medline TA: Sci Transl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 25cm11 Citation Subset: IM |
Affiliation:
|
Oncology Research Unit, Pfizer, San Diego, CA 92121, USA. John.Lamb@pfi zer.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biology Biomedical Research / methods* Biotechnology / methods* Disease* Humans Medicine / methods* |
| Comments/Corrections | |
Comment On:
|
Sci Transl Med. 2010 Mar 24;2(24):24cm10
[PMID:
20375005
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of ADHD documentation from candidates requesting Americans With Disabilities Act (ADA) ac...
Next Document: Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.